We have demonstrated that NGF, NGF relative percentage, or NGF/proNGF ratio might be considered candidate biomarkers for the mentioned neurodegenerative diseases, but an optimization of the assay for NGF, overcoming technical limitations, must be carried out before undertaking the NGF biomarker validation. Here, NGF is linked to neurodegenerative disease.